Suppr超能文献

血管生成素、Tie2和血管内皮生长因子在肝细胞癌血管生成及进展中的表达

Expression of angiopoietins, Tie2 and vascular endothelial growth factor in angiogenesis and progression of hepatocellular carcinoma.

作者信息

Zhang Zhong-Lin, Liu Zhi-Su, Sun Quan

机构信息

Department of General Surgery, Zhongnan Hospital, Wuhan University, No. 169, Donghu Road, Wuhan 430071, Hubei Province, China.

出版信息

World J Gastroenterol. 2006 Jul 14;12(26):4241-5. doi: 10.3748/wjg.v12.i26.4241.

Abstract

AIM

To investigate the significance of angiopoietins, Tie2 and vascular endothelial growth factor (VEGF) expression in the angiogenesis and progress of hepatocellular carcinoma (HCC).

METHODS

Fresh surgically resected specimens of HCC and noncancerous liver (NCL) tissue from 38 patients with HCC were obtained, and expression of angiopoietin-1 (Ang-1), angiopoietin-2 (Ang-2), Tie2, and VEGF messenger RNA (mRNA) was examined by real-time quantitative reverse transcription-polymerase chain reaction (RT-PCR). Expression pattern of each gene in HCC and NCL tissue specimens was compared and the potential role and interaction in angiogenesis of HCC were analyzed. Genes' expression level and its relationship with tumor's clinicopathological parameters were also investigated. Immunohistochemical staining of CD34 was performed to determine the microvessel density (MVD) and Ang-2/Ang-1 ratio was calculated. Relationships between Ang-2/Ang-1 ratio, VEGF and MVD and clinicopathological features were also tested so as to evaluate their significance in the progression of HCC.

RESULTS

Ang-2 and VEGF mRNAs in HCC were significantly higher than those in NCL tissue (P < 0.05), whereas the Ang-1 and Tie2 mRNAs showed no statistical significance (P > 0.05), though slightly lower level of Ang-1 mRNA in HCC was observed. Ang-2/Ang-1 ratio and VEGF were both positively correlated to MVD. The Ang-2/ Ang-1 ratio, Ang-2 and VEGF were all associated with tumor's clinicopathological parameters (P < 0.05) except for histological grades (P > 0.05). Ang-1 and Tie2 levels in different clinicopathological groups were not significantly different (P > 0.05).

CONCLUSION

Dominant Ang-2 expression against Ang-1 through Tie2 receptor in the presence of VEGF plays a critical role in initiating early neovascularization and transformation of noncancerous liver to hepatocellular carcinoma. Its consequently constant operation in formed HCC induces further angiogenesis and progression of HCC.

摘要

目的

探讨血管生成素、Tie2和血管内皮生长因子(VEGF)在肝细胞癌(HCC)血管生成及进展中的表达意义。

方法

获取38例HCC患者手术切除的新鲜HCC及癌旁肝组织(NCL)标本,采用实时定量逆转录-聚合酶链反应(RT-PCR)检测血管生成素-1(Ang-1)、血管生成素-2(Ang-2)、Tie2和VEGF信使核糖核酸(mRNA)的表达。比较各基因在HCC和NCL组织标本中的表达模式,分析其在HCC血管生成中的潜在作用及相互作用。研究基因表达水平及其与肿瘤临床病理参数的关系。进行CD34免疫组化染色以确定微血管密度(MVD)并计算Ang-2/Ang-1比值。检测Ang-2/Ang-1比值、VEGF与MVD及临床病理特征之间的关系,以评估它们在HCC进展中的意义。

结果

HCC中Ang-2和VEGF mRNA显著高于NCL组织(P<0.05),而Ang-1和Tie2 mRNA虽在HCC中略低但无统计学意义(P>0.05)。Ang-2/Ang-1比值和VEGF均与MVD呈正相关。Ang-2/Ang-1比值、Ang-2和VEGF均与肿瘤临床病理参数相关(P<0.05),但与组织学分级无关(P>0.05)。不同临床病理组中Ang-1和Tie2水平无显著差异(P>0.05)。

结论

在VEGF存在的情况下,通过Tie2受体,Ang-2相对于Ang-1的优势表达在启动早期新生血管形成以及非癌性肝向肝细胞癌转化中起关键作用。其在已形成的HCC中持续作用诱导HCC进一步血管生成和进展。

相似文献

3
Angiopoietin switching regulates angiogenesis and progression of human hepatocellular carcinoma.
J Clin Pathol. 2003 Nov;56(11):854-60. doi: 10.1136/jcp.56.11.854.
6
Angiopoietin-2 levels in the hepatic vein as a useful predictor of tumor invasiveness and prognosis in human hepatocellular carcinoma.
J Gastroenterol Hepatol. 2008 Jul;23(7 Pt 2):e157-64. doi: 10.1111/j.1440-1746.2007.05175.x. Epub 2007 Oct 11.
7
Overexpression of VEGF and angiopoietin 2: a key to high vascularity of hepatocellular carcinoma?
Mod Pathol. 2003 Jun;16(6):552-7. doi: 10.1097/01.MP.0000071841.17900.69.
9
The Angiopoietin/Tie2 Pathway in Hepatocellular Carcinoma.
Cells. 2020 Oct 30;9(11):2382. doi: 10.3390/cells9112382.

引用本文的文献

1
Vasomics of the liver.
Gut. 2025 May 7;74(6):1008-1020. doi: 10.1136/gutjnl-2024-334133.
4
Nanosecond pulse effectively ablated hepatocellular carcinoma with alterations in the gut microbiome and serum metabolites.
Front Pharmacol. 2023 May 10;14:1163628. doi: 10.3389/fphar.2023.1163628. eCollection 2023.
5
Immune Aging and How It Works for Inflammation and Fibrosis.
Front Physiol. 2022 Jan 4;12:795508. doi: 10.3389/fphys.2021.795508. eCollection 2021.
6
A Correlative Study Between IVIM-DWI Parameters and the Expression Levels of Ang-2 and TKT in Hepatocellular Carcinoma.
Front Oncol. 2021 Jan 15;10:594366. doi: 10.3389/fonc.2020.594366. eCollection 2020.
7
The Angiopoietin/Tie2 Pathway in Hepatocellular Carcinoma.
Cells. 2020 Oct 30;9(11):2382. doi: 10.3390/cells9112382.
8
Hepatocellular carcinoma treatment: hurdles, advances and prospects.
Hepat Oncol. 2018 Sep 28;5(2):HEP08. doi: 10.2217/hep-2018-0002. eCollection 2018 Apr.
10

本文引用的文献

2
4
Vascular remodeling and clinical resistance to antiangiogenic cancer therapy.
Drug Resist Updat. 2004 Aug-Oct;7(4-5):289-300. doi: 10.1016/j.drup.2004.09.001.
5
Hepatocellular carcinoma: current management and future trends.
Gastroenterology. 2004 Nov;127(5 Suppl 1):S218-24. doi: 10.1053/j.gastro.2004.09.036.
6
Expression and significance of angiopoietin-2 in gastric cancer.
World J Gastroenterol. 2004 May 1;10(9):1382-5. doi: 10.3748/wjg.v10.i9.1382.
7
Overexpression of angiopoietin-1 and angiopoietin-2 in hepatocellular carcinoma.
J Hepatol. 2004 May;40(5):799-807. doi: 10.1016/j.jhep.2004.01.027.
9
Vasculogenesis and angiogenesis.
Cancer Treat Res. 2004;117:3-32. doi: 10.1007/978-1-4419-8871-3_1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验